SHARON MARRS: Open Payments
NPI 1669463907 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 12 payments from 9 companies in 2025. Trend: 2023 $1,028 · 2024 $858 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Bioventus LLC | 1 | $132 |
| Amgen Inc. | 1 | $125 |
| Lundbeck LLC | 2 | $111 |
| Axsome Therapeutics, Inc. | 2 | $92 |
| Lilly USA, LLC | 1 | $79 |
| ABBVIE INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Novo Nordisk Inc | 1 | $18 |
Products named: EXOGEN ULTRASOUND BONE HEALING SYSTEM, EVENITY, VYEPTI, Auvelity, ZEPBOUND, JARDIANCE, AIRSUPRA, Ozempic.
Industry payments across IN — which companies pay providers there.
